The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
LEAPS, 2003High Resolution Whole Genome Study to Determine Genetic Loci of Parkinson's Disease
The Cox team will leverage Perlegen's high-density array technology and the Mayo Clinic's extensive patient database, clinical expertise and DNA bank to create a genetic map of causes and risk factors...
-
The Role of Inflammation in Parkinson's Disease, 2003Spiral Inflammation Hypothesis of Parkinson’ Disease
It is well known that autopsied brains from patients with Parkinson's disease (PD) show evidence of inflammation within the region of the brain thought to be responsible for PD â€" the substantia...
-
The Role of Inflammation in Parkinson's Disease, 2003Role of lymphocyte brain infiltration in neuroinflammation and nerve cell death in Parkinson’s disease
Parkinson's disease is characterized by a slow progression of a specific neuronal population in the brain using dopamine as neurotransmitter. Previous studies performed by several groups of...
-
The Role of Inflammation in Parkinson's Disease, 2003Significance of Complement Activation in the Progression of Parkinson's disease
The complement system is composed of a series of proteins which react with each other in an orderly fashion, producing protein fragments (so-called 'complement activation proteins') which can exert...
-
The Role of Inflammation in Parkinson's Disease, 2003Activation of Receptor for Advanced Glycation Endproducts (RAGE) on Microglia: A Novel Inflammatory Mechanism Contributing to PD Pathogenesis
There is now considerable and growing evidence that Parkinson's disease (PD) is associated with inflammation in the brain. Several small soluble proteins that are commonly secreted during inflammatory...
-
The Role of Inflammation in Parkinson's Disease, 2003The role of IAP-induction in mediation of rythropoietin-induced neuroprotection in rodent models of Parkinson’s disease
Systemic administration of erythropoietin (EPO) has been shown to reduce neuronal cell death and neurological dysfunction in animal models of stroke, epilepsy, head injury and multiple sclerosis (MS)...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.